The world's worst wave of infection is subsiding in India but it hardly seems justified that stocks have risen to all-time highs.
There's one name I've added to today.
Last year's top-performing stock market worldwide has been a disappointment since setting an all-time high in February. Could it have just turned?
My slightly different approach uses a combination of fundamental and technical factors.
We've been caught with our pants down, largely because we had no faith in the smartest people in the country.
I'm more focused on the production, manufacture and transport of materials raw, finished and refined than ever before.
With vaccination levels rising and COVID-19 restrictions continuing to ease, these companies are poised to benefit.
The charts of the life sciences company do not indicate that it is a good time to buy its stock despite how much it already has declined.
FOSL has been overly punished by the markets at times.
Until signs of inflation start to ebb, I will remain cautious within my portfolio.